Hepatitis B vaccine: current progress and strategies for utilization.
D000818:Animals; D002353:Carrier State / Q000276:immunology; D002908:Chronic Disease; D004306:Dose-Response Relationship, Immunologic; D006168:Guinea Pigs; D006509:Hepatitis B / Q000517:prevention & control; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006515:Hepatitis B virus / Q000276:immunology / Q000648:ultrastructure; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D002679:Pan troglodytes; D010956:Plasmapheresis; D014765:Viral Vaccines / Q000592:standards / Q000627:therapeutic use*
D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D007136:Immunoglobulins; D014765:Viral Vaccines